• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 重症监护或住院患者的死亡风险因素:法国国家医疗管理数据库分析。

Risk factors of mortality among patients hospitalised with COVID-19 in a critical care or hospital care unit: analysis of the French national medicoadministrative database.

机构信息

Medical Information Department, Medical information Analysis and Coordination Unit (UCAIM), University Hospital Centre Bordeaux, Bordeaux, France

Medical Information Department, Lille University Hospital Center, Lille, Hauts-de-France, France.

出版信息

BMJ Open Respir Res. 2021 Oct;8(1). doi: 10.1136/bmjresp-2021-001002.

DOI:10.1136/bmjresp-2021-001002
PMID:34711641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8557246/
Abstract

OBJECTIVE

To explore mortality risk factors for patients hospitalised with COVID-19 in a critical care unit (CCU) or a hospital care unit (HCU).

DESIGN

Retrospective cohort analysis using the French national () database.

SETTING

Any public or private hospital in France.

PARTICIPANTS

98 366 patients admitted with COVID-19 for more than 1 day during the first semester of 2020 were included. The underlying conditions were retrieved for all contiguous stays.

MAIN OUTCOME MEASURES

In-hospital mortality and associated risk factors were assessed using frailty Cox models.

RESULTS

Among the 98 366 patients included, 25 765 (26%) were admitted to a CCU. The median age was 66 (IQR: 55-76) years in CCUs and 74 (IQR: 57-85) years in HCUs. Age was the main risk factor of death in both CCUs and HCUs, with adjusted HRs (aHRs) in CCUs increasing from 1.60 (95% CI 1.35 to 1.88) for 46 to 65 years to 8.17 (95% CI 6.86 to 9.72) for ≥85 years. In HCUs, the aHR associated with age was more than two times higher. The gender was not significantly associated with death, aHR 1.03 (95% CI 0.98 to 1.09, p=0.2693) in CCUs. Most of the underlying chronic conditions were risk factors for death, including malignant neoplasm (CCU: 1.34 (95% CI 1.25 to 1.43); HCU: 1.41 (95% CI 1.35 to 1.47)), cirrhosis without transplant (1.41 (95% CI 1.22 to 1.64); 1.27 (95% CI 1.12 to 1.45)) and dementia (1.30 (95% CI 1.16 to 1.46); 1.07 (95% CI 1.03 to 1.12)).

CONCLUSION

This analysis confirms the role of age as the major risk factor of death in patients with COVID-19 irrespective to admission to critical care and therefore supports the current vaccination policies targeting older individuals.

摘要

目的

探讨在重症监护病房(CCU)或医院病房(HCU)住院的 COVID-19 患者的死亡风险因素。

设计

使用法国国家()数据库进行回顾性队列分析。

地点

法国任何一家公立或私立医院。

参与者

纳入 2020 年上半年连续住院超过 1 天的 98366 例 COVID-19 患者。所有连续住院患者均记录其基础疾病。

主要观察指标

采用脆弱性 Cox 模型评估住院死亡率和相关风险因素。

结果

在纳入的 98366 例患者中,25765 例(26%)被收入 CCU。CCU 患者的中位年龄为 66(IQR:55-76)岁,HCU 患者的中位年龄为 74(IQR:57-85)岁。年龄是 CCU 和 HCU 死亡的主要危险因素,CCU 中年龄 46 至 65 岁的调整后 HR(aHR)为 1.60(95%CI 1.35-1.88),年龄≥85 岁的 aHR 为 8.17(95%CI 6.86-9.72)。在 HCU 中,与年龄相关的 aHR 高两倍多。性别与死亡无显著相关性,CCU 的 aHR 为 1.03(95%CI 0.98-1.09,p=0.2693)。大多数基础慢性疾病是死亡的危险因素,包括恶性肿瘤(CCU:1.34(95%CI 1.25-1.43);HCU:1.41(95%CI 1.35-1.47))、无移植的肝硬化(1.41(95%CI 1.22-1.64);1.27(95%CI 1.12-1.45))和痴呆(1.30(95%CI 1.16-1.46);1.07(95%CI 1.03-1.12))。

结论

本分析证实年龄是 COVID-19 患者死亡的主要危险因素,无论入住重症监护病房与否,均支持当前针对老年人的疫苗接种政策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12b5/8557246/44f85de5ea7c/bmjresp-2021-001002f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12b5/8557246/835717219423/bmjresp-2021-001002f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12b5/8557246/4f77560d0ebd/bmjresp-2021-001002f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12b5/8557246/44f85de5ea7c/bmjresp-2021-001002f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12b5/8557246/835717219423/bmjresp-2021-001002f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12b5/8557246/4f77560d0ebd/bmjresp-2021-001002f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12b5/8557246/44f85de5ea7c/bmjresp-2021-001002f03.jpg

相似文献

1
Risk factors of mortality among patients hospitalised with COVID-19 in a critical care or hospital care unit: analysis of the French national medicoadministrative database.COVID-19 重症监护或住院患者的死亡风险因素:法国国家医疗管理数据库分析。
BMJ Open Respir Res. 2021 Oct;8(1). doi: 10.1136/bmjresp-2021-001002.
2
Risk factors for severe outcomes for COVID-19 patients hospitalised in Switzerland during the first pandemic wave, February to August 2020: prospective observational cohort study.2020年2月至8月第一波疫情期间瑞士住院的COVID-19患者出现严重后果的风险因素:前瞻性观察队列研究。
Swiss Med Wkly. 2021 Jul 28;151:w20547. doi: 10.4414/smw.2021.20547. eCollection 2021 Jul 19.
3
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
4
Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.与美国 COVID-19 患者住院死亡率相关的风险因素。
JAMA Netw Open. 2020 Dec 1;3(12):e2029058. doi: 10.1001/jamanetworkopen.2020.29058.
5
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.肝移植受者感染 SARS-CoV-2 后的结局:一项国际注册研究。
Lancet Gastroenterol Hepatol. 2020 Nov;5(11):1008-1016. doi: 10.1016/S2468-1253(20)30271-5. Epub 2020 Aug 28.
6
Risk factors for admission to the pediatric critical care unit among children hospitalized with COVID-19 in France.法国新冠病毒病住院儿童进入儿科重症监护病房的危险因素。
Front Pediatr. 2022 Sep 7;10:975826. doi: 10.3389/fped.2022.975826. eCollection 2022.
7
Comparison of characteristics, predictors and outcomes between the first and second COVID-19 waves in a tertiary care centre in Switzerland: an observational analysis.瑞士一家三级保健中心的第一波和第二波 COVID-19 之间的特征、预测因素和结局比较:一项观察性分析。
Swiss Med Wkly. 2021 Aug 10;151:w20569. doi: 10.4414/smw.2021.20569. eCollection 2021 Aug 2.
8
Ethnic variation in outcome of people hospitalised during the first COVID-19 epidemic wave in Wales (UK): an analysis of national surveillance data using Onomap, a name-based ethnicity classification tool.威尔士(英国)首次 COVID-19 疫情期间住院患者结局的种族差异:使用基于姓名的种族分类工具 Onomap 对国家监测数据的分析。
BMJ Open. 2021 Aug 18;11(8):e048335. doi: 10.1136/bmjopen-2020-048335.
9
Trends in bacterial sepsis incidence and mortality in France between 2015 and 2019 based on National Health Data System (Système National des données de Santé (SNDS)): a retrospective observational study.基于国家健康数据系统(Système National des données de Santé (SNDS))的 2015 年至 2019 年法国细菌脓毒症发病率和死亡率趋势:一项回顾性观察研究。
BMJ Open. 2022 May 24;12(5):e058205. doi: 10.1136/bmjopen-2021-058205.
10
Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort study.加拿大疫情第一阶段住院和重症监护的 COVID-19 患者的特征和结局:一项全国性队列研究。
CMAJ Open. 2021 Mar 8;9(1):E181-E188. doi: 10.9778/cmajo.20200250. Print 2021 Jan-Mar.

引用本文的文献

1
Burden of status epilepticus: prognosis and cost driving factors, insight from a nationwide retrospective cohort study of the French health insurance database.癫痫持续状态的负担:预后和成本驱动因素,来自法国健康保险数据库的全国回顾性队列研究的见解。
J Neurol. 2024 Oct;271(10):6761-6772. doi: 10.1007/s00415-024-12589-6. Epub 2024 Aug 23.
2
Risk of COVID-19 death for people with a pre-existing cancer diagnosis prior to COVID-19-vaccination: A systematic review and meta-analysis.COVID-19 疫苗接种前患有癌症的人群因 COVID-19 死亡的风险:系统评价和荟萃分析。
Int J Cancer. 2024 Apr 15;154(8):1394-1412. doi: 10.1002/ijc.34798. Epub 2023 Dec 11.
3

本文引用的文献

1
Patient factors and temporal trends associated with COVID-19 in-hospital mortality in England: an observational study using administrative data.英格兰 COVID-19 住院患者病死率的相关患者因素和时间趋势:基于行政数据的观察性研究。
Lancet Respir Med. 2021 Apr;9(4):397-406. doi: 10.1016/S2213-2600(20)30579-8. Epub 2021 Feb 15.
2
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
3
Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study.
Effects of the pre-existing coronary heart disease on the prognosis of COVID-19 patients: A systematic review and meta-analysis.
既往冠心病对 COVID-19 患者预后的影响:系统评价和荟萃分析。
PLoS One. 2023 Oct 10;18(10):e0292021. doi: 10.1371/journal.pone.0292021. eCollection 2023.
4
Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2.专家共识:影响 COVID-19 预后不良的主要危险因素及其对靶向 SARS-CoV-2 措施的影响。
Viruses. 2023 Jun 27;15(7):1449. doi: 10.3390/v15071449.
5
Major interregional differences in France of COVID-19 hospitalization and mortality from January to June 2020.2020 年 1 月至 6 月法国 COVID-19 住院和死亡率的主要地区间差异。
Rev Epidemiol Sante Publique. 2022 Nov;70(6):265-276. doi: 10.1016/j.respe.2022.08.008. Epub 2022 Sep 13.
6
COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study.COVID-19 与肺动脉高压患者:一项全国性前瞻性队列研究。
Am J Respir Crit Care Med. 2022 Sep 1;206(5):573-583. doi: 10.1164/rccm.202112-2761OC.
比较 COVID-19 和季节性流感的特征、发病率和死亡率:一项全国性、基于人群的回顾性队列研究。
Lancet Respir Med. 2021 Mar;9(3):251-259. doi: 10.1016/S2213-2600(20)30527-0. Epub 2020 Dec 17.
4
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
5
Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.与美国 COVID-19 患者住院死亡率相关的风险因素。
JAMA Netw Open. 2020 Dec 1;3(12):e2029058. doi: 10.1001/jamanetworkopen.2020.29058.
6
Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection.美国癌症和 COVID-19 感染患者的风险、种族差异和结局分析。
JAMA Oncol. 2021 Feb 1;7(2):220-227. doi: 10.1001/jamaoncol.2020.6178.
7
Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications.评估 COVID-19 感染病死率的年龄特异性:系统评价、荟萃分析及公共政策意义。
Eur J Epidemiol. 2020 Dec;35(12):1123-1138. doi: 10.1007/s10654-020-00698-1. Epub 2020 Dec 8.
8
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.在年轻和老年成年人中进行的一次单盲、随机、对照、2/3 期试验中,观察 ChAdOx1 nCoV-19 疫苗在初免-加强免疫方案中的安全性和免疫原性(COV002)。
Lancet. 2021 Dec 19;396(10267):1979-1993. doi: 10.1016/S0140-6736(20)32466-1. Epub 2020 Nov 19.
9
COVID-19 outcomes in UK centre within highest health and wealth band: a prospective cohort study.英国处于最高健康和财富水平的中心的 COVID-19 结局:一项前瞻性队列研究。
BMJ Open. 2020 Nov 16;10(11):e042090. doi: 10.1136/bmjopen-2020-042090.
10
Coping with Dementia in the Middle of the COVID-19 Pandemic.应对 COVID-19 大流行中的痴呆症。
J Korean Med Sci. 2020 Nov 2;35(42):e383. doi: 10.3346/jkms.2020.35.e383.